150 related articles for article (PubMed ID: 4555784)
1. Suppressive effect of secretin upon pancreatic alpha cell function.
Santeusanio F; Faloona GR; Unger RH
J Clin Invest; 1972 Jul; 51(7):1743-9. PubMed ID: 4555784
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
Boden G; Essa N; Owen OE; Reichle FA
J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
[TBL] [Abstract][Full Text] [Related]
3. Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs.
Koizumi F; Ohkawa A; Kawamura T; Ishimori A; Sasaki I; Kameyama J
Diabetologia; 1986 Apr; 29(4):238-43. PubMed ID: 3519339
[TBL] [Abstract][Full Text] [Related]
4. The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes.
Braaten JT; Faloona GR; Unger RH
J Clin Invest; 1974 Apr; 53(4):1017-21. PubMed ID: 4592597
[TBL] [Abstract][Full Text] [Related]
5. Abnormal alpha cell function in diabetics response to insulin.
Unger RH; Madison LL; Muller WA
Diabetes; 1972 May; 21(5):301-7. PubMed ID: 24683634
[TBL] [Abstract][Full Text] [Related]
6. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.
Unger RH; Ketterer H; Dupré J; Eisentraut AM
J Clin Invest; 1967 Apr; 46(4):630-45. PubMed ID: 4290022
[TBL] [Abstract][Full Text] [Related]
7. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
Ohneda A; Parada E; Eisentraut AM; Unger RH
J Clin Invest; 1968 Oct; 47(10):2305-22. PubMed ID: 5676526
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
Sakurai H; Dobbs R; Unger RH
J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
[TBL] [Abstract][Full Text] [Related]
9. The effect of alanine on glucagon secretion.
Müller WA; Faloona GR; Unger RH
J Clin Invest; 1971 Oct; 50(10):2215-8. PubMed ID: 5116210
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
Schusdziarra V; Lenz N; Schick R; Maier V
Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
[TBL] [Abstract][Full Text] [Related]
12. Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs.
Adrogué HJ; Chap Z; Ishida T; Field JB
J Clin Invest; 1985 Mar; 75(3):798-808. PubMed ID: 3884666
[TBL] [Abstract][Full Text] [Related]
13. The role of aminogenic glucagon secretion in blood glucose homeostasis.
Unger RH; Ohneda A; Aguilar-Parada E; Eisentraut AM
J Clin Invest; 1969 May; 48(5):810-22. PubMed ID: 5780193
[TBL] [Abstract][Full Text] [Related]
14. The effect of experimental insulin deficiency on glucagon secretion.
Müller WA; Faloona GR; Unger RH
J Clin Invest; 1971 Sep; 50(9):1992-9. PubMed ID: 4935445
[TBL] [Abstract][Full Text] [Related]
15. [Absence of effect of secretin and cholecystokinin on plasma concentrations of vasoactive intestinal polypeptide and pancreatic glucagon].
Bauer FE; Schulz E; Janisch HD; von Kleist D; Hampel KE
Wien Klin Wochenschr; 1985 Jul; 97(14):603-5. PubMed ID: 3901535
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
[TBL] [Abstract][Full Text] [Related]
17. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
Greenbaum CJ; Havel PJ; Taborsky GJ; Klaff LJ
J Clin Invest; 1991 Sep; 88(3):767-73. PubMed ID: 1679440
[TBL] [Abstract][Full Text] [Related]
18. Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes.
Starke A; Grundy S; McGarry JD; Unger RH
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1544-6. PubMed ID: 3883362
[TBL] [Abstract][Full Text] [Related]
19. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
Perez G; Kemmer FW; Lickley HL; Vranic M
Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
[TBL] [Abstract][Full Text] [Related]
20. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
